Temporal and mechanistic effects of heat shock on LPS-mediated degradation of IkappaBalpha in macrophages.
Previous studies demonstrated important interactions between the heat shock response and the IkappaBalpha/NF-kappaB pathway when these two pathways are induced sequentially. One such interaction involves the ability of heat shock to inhibit subsequent degradation of IkappaBalpha in response to a proinflammatory signal. Herein we investigated the temporal relationship between recovery from heat shock and inhibition of IkappaBalpha degradation, and the proximal mechanisms by which heat shock inhibits degradation of IkappaBalpha in macrophages. In RAW 264.7 murine macrophages, prior heat shock inhibited LPS-mediated IkappaBalpha degradation up to 4 h after recovery from heat shock, and this effect correlated with inhibition of LPS-mediated activation of NF-kappaB. Beyond these recovery periods, heat shock did not inhibit IkappaBalpha degradation. IkappaB kinase (IKK) assays demonstrated that heat shock inhibited LPS-mediated activation of IKK up to 1 h after recovery from heat shock. Heat shock also increased intracellular phosphatase activity, and inhibition of intracellular phosphatase activity partially reversed the ability of heat shock to inhibit both LPS-mediated degradation of IkappaBalpha and LPS-mediated activation of IKK. These data demonstrate that the ability of heat shock to inhibit degradation of IkappaBalpha is dependent on the recovery period between the heat shock stimulus and the proinflammatory stimulus. The mechanism by which heat shock inhibits degradation of IkappaBalpha involves dual modulation of IKK and intracellular phosphatase activity.
Grossman
Bruce J
BJ
Division of Critical Care Medicine, Children's Hospital Medical Center, and Children's Hospital Research Foundation, Cincinnati, OH 45229-3039, USA.
Shanley
Thomas P
TP
Odoms
Kelli
K
Dunsmore
Katherine E
KE
Denenberg
Alvin G
AG
Wong
Hector R
HR
D000818:Animals; D002460:Cell Line; D018869:Heat-Shock Response; D020672:I-kappa B Proteins / Q000378:metabolism*; D007155:Immunologic Factors / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008264:Macrophages / Q000378:metabolism*; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism*; D010744:Phosphoric Monoester Hydrolases / Q000037:antagonists & inhibitors / Q000378:metabolism; D010766:Phosphorylation; D013997:Time Factors
D020672:I-kappa B Proteins; D007155:Immunologic Factors; D008070:Lipopolysaccharides; D016328:NF-kappa B; D010744:Phosphoric Monoester Hydrolases